Long-term survival in a case of high-risk type IgD myeloma; a possibility of effectiveness of interferon-α and erythropoietin

Haematologia

Volumn 28, Issue 3, 1997, Pages 177-180

  Hiyoshi, Motofumi ^a   Hashimoto, Shigemi ^a   Ota, Tadanobu ^a   Nakao, Takafumi ^a   Takubo, Takayuki ^a   Tagawa, Shinichi ^a   Tatsumi, Noriyuki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

erythropoietin; IgD myeloma; Interferon ; Multiple myeloma

Indexed keywords

ALPHA INTERFERON; ERYTHROPOIETIN; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ANEMIA; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MULTIPLE MYELOMA; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; ERYTHROPOIETIN; HUMANS; IMMUNOGLOBULIN D; INTERFERON-ALPHA; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PROGNOSIS; TIME FACTORS;

EID: 0030792050     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Fahey, J. L., Carbone, P. P., Rowe, D. S., Bachmann, R.: Plasma cell myeloma with D myeloma protein (IgD myeloma). Am. J. Med. 45, 373 (1968).
2. Westin, J., Rodjer, S., Turesson, I., Cortelezzi, A., Hjorth, M., Zador, G.: Interferon alfa-2b versus no maintenance therapy during the plateu phase in multiple myeloma: a randomized study. Cooperative Study Group. Br. J. Haematol. 89, 561 (1995).
3. Camba, L., Durie, B. G.: Multiple myeloma. New treatment options. Drugs 44, 170 (1992).
4. Ludwig, H., Fritz, E., Kotzmann, H., Hocker, P., Gisslinger, H., Barnas, U.: Erythropoietin treatment of anemia associated with multiple myeloma. N. Engl. J. Med. 322, 1693 (1990).
5. Shimamoto, Y., Anami, Y., Yamaguchi, M.: A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients. Eur. J. Haematol. 47, 262 (1991).
6. Suzuki, A., Iwase, O., Ohkubo, T., Nakano, M., Toyama, K.: The successful use of natural alpha-interferon single therapy in multiple myeloma of IgD (lambda)-type. Jpn. J. Clin. Haematol. 32, 47 (1991).
7. Barlogie, B.: Treatment of the anemia of multiple myeloma: the role of recombinant human erythropoietin. Semin. Haematol. 30 (suppl. 6), 25 (1993).